Stability of exenatide in poly(D,L-lactide-co-glycolide) solutions: A simplified investigation on the peptide degradation by the polymer

被引:20
作者
Liang, Rongcai [1 ,2 ,3 ]
Zhang, Renyu [2 ,3 ]
Li, Xiang [2 ,3 ]
Wang, Aiping [1 ,3 ]
Chen, Daquan [1 ]
Sun, Kaoxiang [1 ,3 ]
Liu, Wanhui [1 ,3 ]
Li, Youxin [2 ,3 ]
机构
[1] Yantai Univ, Sch Pharm, Yantai 264005, Shandong, Peoples R China
[2] Jilin Univ, Coll Life Sci, Changchun 130012, Jilin Province, Peoples R China
[3] State Key Lab Long Acting & Targeting Drug Delive, Yantai 264003, Shandong, Peoples R China
关键词
Exenatide; Stability; Acylation; Poly(D; L-lactide-co-glycolide) (PLGA); Solution model; PROTEIN INSTABILITY; IMPURITY FORMATION; PLGA MICROSPHERES; MEDIUM-DEPENDENCE; ACYLATION; ACID); EXENDIN-4; RELEASE; FORMULATION; ENVIRONMENT;
D O I
10.1016/j.ejps.2013.08.014
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
A solution model can be used to elucidate drug stability issues in a complex system. The aim of this study was to investigate the interaction between poly(D,L-lactide-co-glycolide) (PLGA) and exenatide in organic solvent-acetate buffer saline (ABS) solutions. The effect of solvent composition on exenatide stability was investigated first. In the selected 90:10 dimethyl sulfoxide (DMSO):ABS solution, exenatide stability was examined as a function of PLGA comonomer ratios, molecular weight (Mw) and concentrations. The specific rotation analysis and second derivative UV absorbance spectroscopy were used to monitor the variation of exenatide higher order structure. The effect of ABS pH on the interaction was also investigated. Exenatide degradation products were characterized by HPLC-MS/MS. It was found that exenatide was relatively stable in glacial acetic acid (HAc)-ABS solutions, whereas DMSO content had a strong influence on the conformation state and stability of exenatide. PLGA 50:50 promoted exenatide degradation more than PLGA 75:25 and poly(ox-lactide) (PLA). Lower Mw and higher concentration of PLGA were beneficial for exenatide degradation. Exenatide was more stable in 90:10 DMSO:ABS (pH 3.0) solution than in 90:10 DMSO:ABS (pH 4.5 and 3.0) solutions during the incubation. HPLC-MS/MS analysis of exenatide demonstrated that acylation was the main degradation route of the peptide. (C) 2013 Elsevier B.V. All rights reserved.
引用
收藏
页码:502 / 510
页数:9
相关论文
共 42 条
[1]   Medium-dependence of the secondary structure of exendin-4 and glucagon-like-peptide-1 [J].
Andersen, NH ;
Brodsky, Y ;
Neidigh, JW ;
Prickett, KS .
BIOORGANIC & MEDICINAL CHEMISTRY, 2002, 10 (01) :79-85
[2]   The fatty acid conjugated exendin-4 analogs for type 2 antidiabetic therapeutics [J].
Chae, Su Young ;
Choi, Yang Gyu ;
Son, Sohee ;
Jung, Sung Youb ;
Lee, Doo Sung ;
Lee, Kang Choon .
JOURNAL OF CONTROLLED RELEASE, 2010, 144 (01) :10-16
[3]   Biochemical, pharmaceutical and therapeutic properties of long-acting lithocholic acid derivatized exendin-4 analogs [J].
Chae, Su Young ;
Jin, Cheng-Hao ;
Shin, Jae Hee ;
Son, Sohee ;
Kim, Tae Hyung ;
Lee, Seulki ;
Youn, Yu Seok ;
Byun, Youngro ;
Lee, Myung-Shik ;
Lee, Kang Choon .
JOURNAL OF CONTROLLED RELEASE, 2010, 142 (02) :206-213
[4]   Stability of synthetic exendin-4 in human plasma in vitro [J].
Chen, Jie ;
Yu, Ling ;
Wang, Liping ;
Fang, Xuexun ;
Li, Li ;
Li, Wei .
PROTEIN AND PEPTIDE LETTERS, 2007, 14 (01) :19-25
[5]   CONTROLLED DELIVERY SYSTEMS FOR PROTEINS BASED ON POLY(LACTIC GLYCOLIC ACID) MICROSPHERES [J].
COHEN, S ;
YOSHIOKA, T ;
LUCARELLI, M ;
HWANG, LH ;
LANGER, R .
PHARMACEUTICAL RESEARCH, 1991, 8 (06) :713-720
[6]   Quality analysis of salmon calcitonin in a polymeric bioadhesive pharmaceutical formulation: Sample preparation optimization by DOE [J].
D'Hondt, Matthias ;
Van Dorpe, Sylvia ;
Mehuys, Els ;
Deforce, Dieter ;
De Spiegeleer, Bart .
JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS, 2010, 53 (04) :939-945
[7]   Exenatide [J].
Davidson, MB ;
Bate, G ;
Kirkpatrick, P .
NATURE REVIEWS DRUG DISCOVERY, 2005, 4 (09) :713-714
[8]   Protein stability in the presence of polymer degradation products: Consequences for controlled release formulations [J].
Determan, AS ;
Wilson, JH ;
Kipper, MJ ;
Wannemuehler, MJ ;
Narasimhan, B .
BIOMATERIALS, 2006, 27 (17) :3312-3320
[9]   Encapsulation of Exenatide in Poly-(D,L-Lactide-Co-Glycolide) Microspheres Produced an Investigational Long-Acting Once-Weekly Formulation for Type 2 Diabetes [J].
DeYoung, Mary Beth ;
MacConell, Leigh ;
Sarin, Viren ;
Trautmann, Michael ;
Herbert, Paul .
DIABETES TECHNOLOGY & THERAPEUTICS, 2011, 13 (11) :1145-1154
[10]   Acidic Microclimate pH Distribution in PLGA Microspheres Monitored by Confocal Laser Scanning Microscopy [J].
Ding, Amy G. ;
Schwendeman, Steven P. .
PHARMACEUTICAL RESEARCH, 2008, 25 (09) :2041-2052